198 related articles for article (PubMed ID: 23095661)
1. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study.
Tadewos A; Addis Z; Ambachew H; Banerjee S
AIDS Res Ther; 2012 Oct; 9(1):31. PubMed ID: 23095661
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
[TBL] [Abstract][Full Text] [Related]
4. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.
Pefura Yone EW; Betyoumin AF; Kengne AP; Kaze Folefack FJ; Ngogang J
AIDS Res Ther; 2011 Sep; 8():33. PubMed ID: 21943115
[TBL] [Abstract][Full Text] [Related]
5. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.
Manuthu EM; Joshi MD; Lule GN; Karari E
East Afr Med J; 2008 Jan; 85(1):10-7. PubMed ID: 18543521
[TBL] [Abstract][Full Text] [Related]
7. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study.
Jemal M; Shibabaw Molla T; Tiruneh G Medhin M; Chekol Abebe E; Asmamaw Dejenie T
Ann Med; 2023; 55(2):2295435. PubMed ID: 38118463
[TBL] [Abstract][Full Text] [Related]
8. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.
Lazzaretti RK; Kuhmmer R; Sprinz E; Polanczyk CA; Ribeiro JP
J Am Coll Cardiol; 2012 Mar; 59(11):979-88. PubMed ID: 22402068
[TBL] [Abstract][Full Text] [Related]
9. Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India.
Pujari SN; Dravid A; Naik E; Bhagat S; Tash K; Nadler JP; Sinnott JT
J Acquir Immune Defic Syndr; 2005 Jun; 39(2):199-202. PubMed ID: 15905737
[TBL] [Abstract][Full Text] [Related]
10. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
[TBL] [Abstract][Full Text] [Related]
12. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
13. Impact of HIV infection and HAART on serum lipids in men.
Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy.
Li X; Song X; Han Y; Qiu Z; Cao W; Li T
BMC Infect Dis; 2023 Sep; 23(1):598. PubMed ID: 37705002
[TBL] [Abstract][Full Text] [Related]
15. Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Muche Belete A; Seifu D; Menon M; Amogne W; Shewa A; Adela Tefera A
HIV AIDS (Auckl); 2021; 13():217-227. PubMed ID: 33642881
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
Rahman AP; Eaton SA; Nguyen ST; Bain AM; Payne KD; Bedimo R; Busti AJ
Pharmacotherapy; 2008 Jul; 28(7):913-9. PubMed ID: 18576906
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia.
Tilahun A; Chekol E; Teklemaryam AB; Agidew MM; Tilahun Z; Admassu FT; Dagnaw N; Mengstie MA; Amsalu A; Mengistu EF; Akelew Y; Asmamaw T; Bantie B
Heliyon; 2022 Nov; 8(11):e11342. PubMed ID: 36387433
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
19. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S; Sani MU; Okeahialam BN
Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
